Evidence map›Paper›PMID 31113891›Full record

ArticlemBio2019

Mycofactocin Is Associated with Ethanol Metabolism in Mycobacteria.

Gopinath Krishnamoorthy, Peggy Kaiser, Laura Lozza, Karin Hahnke, Hans-Joachim Mollenkopf, Stefan H E Kaufmann

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The catabolism of ethylene glycol byApplied and environmental microbiology · 2024
    Article
  9. Article
  10. ACS chemical biology · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. FX11 limitsDisease models & mechanisms · 2020
    Article
  18. Review
  19. Impact of Oxygen Supply and Scale Up onFrontiers in bioengineering and biotechnology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Gopinath KrishnamoorthyDepartment of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany krishnamoorthy@mpiib-berlin.mpg.de kaufmann@mpiib-berlin.mpg.de.
Peggy KaiserDepartment of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.
Laura LozzaDepartment of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.
Karin HahnkeDepartment of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.
Hans-Joachim MollenkopfCore Facility Microarray/Genomics, Max Planck Institute for Infection Biology, Berlin, Germany.
Stefan H E KaufmannDepartment of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany krishnamoorthy@mpiib-berlin.mpg.de kaufmann@mpiib-berlin.mpg.de.
Max Planck Institute for Infection Biology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycofactocin (MFT) belongs to the class of ribosomally synthesized and posttranslationally modified peptides conserved in many

Indexed as

Biological FactorsBiosynthetic PathwaysCholesterolEthanolGene DeletionMycobacterium marinumMycobacterium smegmatisMycobacterium tuberculosisPeptidesBiological FactorsCholesterolEthanolPeptidesethanol oxidationMycobacterium tuberculosismycofactocinpyrroloquinoline quinoneredox cofactorribosomally synthesized and posttranslationally modified peptides

Identifiers

PMID31113891
PMCPMC6529628
OpenAlexW2946481596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.